title: [Role of probiotics in treatment of nonalcoholic fatty liver disease].
abstract: Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in China and manifests as simple fatty liver, non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. Studies have shown that intestinal flora can affect the development and progression of NAFLD via the "gut-liver axis" . Probiotics are active microorganisms with beneficial effects on the host, and more and more studies have found that probiotics play a positive role in improving NAFLD. They are cheaper, less harmful, and safer compared with antibiotics and surgery, and therefore, it may become a new method for the prevention and treatment of NAFLD. This article reviews the research advances in probiotics in the treatment of NAFLD, in order to provide a basis for the treatment of NAFLD using probiotics.
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: M
authors.initials: M
authors.lastname: Chen
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: M C
authors.initials: MC
authors.lastname: Wang
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: R
authors.initials: R
authors.lastname: Ni
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: L
authors.initials: L
authors.lastname: Wang
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: G N
authors.initials: GN
authors.lastname: Wang
authors.affiliation: Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Department of Hepatology, Lanzhou University Second Hospital, Lanzhou 730030, China.
authors.forename: L Y
authors.initials: LY
authors.lastname: Zhang
mesh_terms: D002681:China; D005234:Fatty Liver; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000628:therapy*; D019936:Probiotics / Q000627:therapeutic use*
keywords: Intestinal flora; Nonalcoholic fatty liver disease; Probiotics